Clinical trials: Biomarkers / Hair

Cicatricial Alopecia

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

• Completed
• Age: 18 years and older
• Phase 2
• Results posted

Alopecia could be subdivided into two main groups of diseases: non-scarring alopecia, such as male pattern baldness, or alopecia areata (AA), in which hair follicles are preserved, yet quiescent, and scarring alopecia, also known…

Trial name

NCT05076006

Testing

PF-06700841

Where

United States

Volunteers

51 people

Sponsor

Emma Guttman